US2019210974A1PendingUtilityA1

Diarylhydantoin compounds

Assignee: UNIV CALIFORNIAPriority: May 13, 2005Filed: Dec 21, 2018Published: Jul 11, 2019
Est. expiryMay 13, 2025(expired)· nominal 20-yr term from priority
A61P 35/00A61P 17/10A61P 13/08A61P 17/14C07D 233/70C07D 233/74C07D 235/02C07D 233/86C07D 471/10
70
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.

Claims

exact text as granted — not AI-modified
1 .- 51 . (canceled) 
     
     
         52 . The compound having the formula

Join the waitlist — get patent alerts

Track US2019210974A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.